Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

EvolutionMedicine

#2 The Evolutionary Lesson of Xigris

02 Sep 2016

Description

Eli Lilly had a blockbuster drug for sepsis that would save millions of lives. 10 years later, the FDA recommended that Xigris be withdrawn from the market. Remarkably, Eli Lilly profited from this ineffective drug most of the time it was under patent. What lesson from Xigris’s failure can we learn about the immune system, about sepsis, and evolution?

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.